京新药业 (002020.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

14.2x

EV/EBITDA

9.3x

Market Cap

CNY 10.93B

MomentumView details →

1D Return

−3.72%

YTD Return

−33.19%

RSI (14)

38.8

ValuationView details →

P/E (Fwd)

14.2x

EV/EBITDA

9.3x

Market Cap

CNY 10.93B

RSI (14)

38.8

MomentumView details →

1D Return

−3.72%

YTD Return

−33.19%

ProfitabilityView details →

Gross Margin

50.94%

Net Margin

18.83%

EBITDA Margin

28.52%

ROE (TTM)

12.47%

ROA (TTM)

9.43%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

−0.43%

EPS YoY

+10.23%

FCF YoY

+136.23%

Revenue CAGR 3Y

+2.49%

EPS CAGR 3Y

+6.11%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.23

EPS Surprise

−14.81%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.22

Avg Surprise (4Q)

−14.81%

Rev Surprise

−6.74%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

2.03x

Quick Ratio

1.51x

Div Yield

2.76%

Div Rate

CNY 0.35

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

4.04B

Net Income (TTM)

759.89M

Op. CF (TTM)

800.31M

Next earningsOct 23, 2026 →

Latest newsMore news →

Zhejiang Jingxin Pharmaceutical Co., Ltd. reported a decline in profit for the first half of 2026, with net earnings of RMB351.62 million and revenue of RMB1.987 billion.9d ago

Similar companies

泰禾股份301665.SZ 三全食品002216.SZ 卡倍亿300863.SZ 敷尔佳301371.SZ 意华股份002897.SZ 宇顺电子002289.SZ Find similar companies →

Latest newsMore news →

Zhejiang Jingxin Pharmaceutical Co., Ltd. reported a decline in profit for the first half of 2026, with net earnings of RMB351.62 million and revenue of RMB1.987 billion.9d ago